Smith Group Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
NAMA
Smith Group Asset Management's CDNA Position: Q1 2022 in Review
Smith Group Asset Management sold out of CareDx (CDNA) in Q1 2022, closing a stake of 60 shares — an estimated $3K sold.
Smith Group Asset Management first reported a position in CDNA in Q3 2019 and held it in 10 quarters. The position peaked at $120K in Q4 2020. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.
- Smith Group Asset Management reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
- Smith Group Asset Management sold 60 CareDx shares in Q1 2022, an estimated $3K.
- Smith Group Asset Management first reported a position in CareDx in Q3 2019 and held it in 10 quarters.
- Smith Group Asset Management's CareDx position peaked at $120K in Q4 2020.
- 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.
Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.